Kainos Medicine Inc (284620) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
Kainos Medicine Inc (284620) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting ₩0.00 (capex ₩0.00 ) from operating cash flow of ₩208.76 Million. Check 284620 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
₩0.00
Capex + Investments
Operating Cash Flow
₩208.76 Million
KRW
Capital Expenditures
₩0.00
KRW
Kainos Medicine Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Kainos Medicine Inc across 1 annual periods. Explore Kainos Medicine Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Kainos Medicine Inc (2019–2019)
Year-by-year capital reinvestment analysis for Kainos Medicine Inc. For live market cap and broader valuation context, see 284620 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.00x | ₩0.00 | ₩185.74 Million | ₩0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow